Glutamine depletion in patients with Crimean-Congo hemorrhagic fever

Hüseyin Aydin1, Aynur Engin2, Sami Keleş3

  • 1Department of Biochemistry, Sivas Cumhuriyet University School of Medicine, Sivas, Turkey.

Insights

This study reveals altered plasma amino acid levels in Crimean-Congo hemorrhagic fever (CCHF) patients, with lower glutamine and higher aspartate, glutamate, and gamma-aminobutyric acid. These findings offer insights into CCHF pathophysiology and potential supportive treatments.

Area of Science:

  • Biochemistry
  • Virology
  • Clinical Medicine

Background:

  • Crimean-Congo hemorrhagic fever (CCHF) is a severe viral illness with limited understanding of its metabolic alterations.
  • Plasma amino acid profiles in CCHF patients remain largely uncharacterized, hindering insights into disease mechanisms.

Purpose of the Study:

  • To investigate plasma amino acid levels in CCHF patients.
  • To explore the association between specific amino acid levels and CCHF disease severity.

Main Methods:

  • Liquid chromatography-mass spectrometry was employed to measure plasma concentrations of key amino acids: glutamine (Gln), glutamate (Glu), asparagine (Asn), aspartate (Asp), and gamma-aminobutyric acid (GABA).
  • Comparison of amino acid levels between CCHF patients and healthy controls, and between fatal and non-fatal CCHF cases.

Main Results:

  • CCHF patients exhibited significantly lower plasma Gln levels compared to controls.
  • Elevated plasma levels of Asp, Glu, and GABA were observed in CCHF patients.
  • Fatal CCHF cases showed increased Asn and decreased GABA levels.

Conclusions:

  • This research is the first to report on plasma Gln, Glu, Asn, Asp, and GABA levels in CCHF.
  • Altered amino acid profiles in CCHF may play a role in disease pathophysiology and immune response.
  • Understanding these metabolic changes could inform supportive treatment strategies for CCHF.